V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003739 | 300002620 | 1.63 | 64.9 | Neo-adjuvant (N) | 2013-12-10 | 2013-12-22 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300016635 | CISPLATIN + FLUOROURACIL |
| 300003740 | 300002621 | 1.76 | 87 | Neo-adjuvant (N) | 2017-07-17 | 2017-07-17 | Cisplatin + Docetaxel +Fluorouracil | null | null | 300016636 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003741 | 300005987 | 1.75 | 39.1 | Curative (C) | 2018-01-25 | 2018-01-27 | CETUXIMAB + RT | N | Y | 300016639 | CETUXIMAB + RT |
| 300003742 | 300002622 | 1.62 | 84.6 | Neo-adjuvant (N) | 2015-12-25 | 2016-01-15 | CISPLATIN + FLUOROURACIL | 02 | N | 300016643 | CISPLATIN + FLUOROURACIL |
| 300003743 | 300002622 | 1.67 | 45 | null | 2015-09-21 | 2015-10-09 | CETUXIMAB | null | null | 300016643 | CETUXIMAB |
| 300003744 | 300002623 | 1.56 | null | Curative (C) | null | 2013-10-02 | Cisplatin + Docetaxel +Fluorouracil | N | null | 300016647 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003745 | 300002623 | 1.71 | 66.6 | Curative (C) | 2017-11-08 | 2017-11-15 | CETUXIMAB | 02 | Y | 300016647 | CETUXIMAB |
| 300003746 | 300002623 | 1.75 | null | Adjuvant (A) | 2013-07-16 | 2013-07-16 | CETUXIMAB | N | N | 300016647 | CETUXIMAB |
| 300003747 | 300002624 | 1.73 | 96.6 | Adjuvant (A) | 2015-06-14 | 2015-07-17 | Capecitabine | N | N | 300016673 | CAPECITABINE |
| 300003748 | 300002624 | 1.8 | 87 | Neo-adjuvant (N) | 2015-06-30 | 2015-07-07 | Capecitabine | 02 | N | 300016673 | CAPECITABINE |
| 300003749 | 300002625 | 1.6 | 68.4 | Palliative (P) | 2013-06-07 | 2013-06-26 | Trial Unspecified | 02 | N | 300016684 | TRIAL |
| 300003750 | 300002626 | 1.64 | null | null | 2014-10-07 | 2014-10-16 | CARBOPLATIN + PACLITAXEL | N | N | 300016690 | CARBOPLATIN + PACLITAXEL |
| 300003751 | 300002626 | 1.48 | 77 | Neo-adjuvant (N) | 2017-12-21 | 2017-12-31 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300016690 | CISPLATIN + FLUOROURACIL |
| 300003752 | 300002626 | null | null | Curative (C) | 2014-11-01 | 2014-11-11 | CETUXIMAB + RT | N | N | 300016690 | CETUXIMAB + RT |
| 300003753 | 300002627 | 1.75 | 75.9 | Adjuvant (A) | 2016-03-28 | 2016-04-04 | Capecitabine | 02 | N | 300016709 | CAPECITABINE |
| 300003754 | 300002628 | 1.59 | 99.4 | null | 2014-06-19 | 2014-06-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300016712 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003755 | 300002628 | null | null | Adjuvant (A) | 2016-06-22 | 2016-07-12 | Capecitabine | 02 | N | 300016712 | CAPECITABINE |
| 300003756 | 300002629 | 1.62 | 63 | Adjuvant (A) | 2017-07-10 | 2017-07-23 | Capecitabine | 02 | N | 300016724 | CAPECITABINE |
| 300003757 | 300002630 | 1.58 | 114 | Adjuvant (A) | 2017-09-15 | 2017-09-20 | Cetuximab + Radiotherapy Load | N | Y | 300016727 | CETUXIMAB + RT |
| 300003758 | 300002631 | 1.65 | 78.2 | Curative (C) | 2017-07-24 | 2017-08-09 | CETUXIMAB | N | null | 300016735 | CETUXIMAB |
| 300003759 | 300002631 | null | null | Curative (C) | 2016-08-29 | 2016-09-03 | CISPLATIN + FLUOROURACIL | N | N | 300016735 | CISPLATIN + FLUOROURACIL |
| 300003760 | 300002631 | 1.53 | 67 | Not known (9) | 2013-08-19 | 2013-09-26 | Carboplatin + Paclitaxel (3 weekly) | N | null | 300016735 | CARBOPLATIN + PACLITAXEL |
| 300003761 | 300002632 | 1.74 | 120.6 | Palliative (P) | 2014-07-02 | 2014-07-03 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300016741 | CARBOPLATIN + PACLITAXEL |
| 300003762 | 300002633 | 1.68 | 86.4 | null | null | 2013-07-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300016743 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003764 | 300002635 | 1.69 | null | Neo-adjuvant (N) | 2017-09-01 | 2017-09-01 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300016750 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003765 | 300002636 | 1.91 | 49.6 | Curative (C) | 2014-02-22 | 2014-03-01 | CETUXIMAB + RT | N | Y | 300016755 | CETUXIMAB + RT |
| 300003766 | 300002637 | 1.92 | null | Neo-adjuvant (N) | 2013-05-30 | 2013-06-12 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300016761 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003767 | 300002637 | null | 62.3 | Curative (C) | null | 2014-05-19 | CETUXIMAB | null | Y | 300016761 | CETUXIMAB |
| 300003768 | 300002638 | 1.75 | 82 | Neo-adjuvant (N) | 2014-02-07 | 2014-02-07 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300016771 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003769 | 300002639 | 1.64 | 82.1 | null | 2016-03-18 | 2016-03-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 01 | null | 300016772 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003770 | 300002640 | 1.5 | null | Palliative (P) | 2014-10-21 | 2014-11-06 | Capecitabine | N | N | 300016776 | CAPECITABINE |
| 300003771 | 300002641 | 1.78 | 63 | Neo-adjuvant (N) | 2014-04-17 | 2014-04-24 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016795 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003772 | 300002642 | 1.58 | 88 | Palliative (P) | 2017-11-28 | 2017-11-29 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300016797 | CARBOPLATIN + PACLITAXEL |
| 300003773 | 300002643 | null | null | Palliative (P) | 2014-03-26 | 2014-03-27 | Capecitabine | N | N | 300016801 | CAPECITABINE |
| 300003775 | 300002644 | null | null | null | 2016-05-16 | 2016-06-11 | CISPLATIN + FLUOROURACIL | N | Y | 300016804 | CISPLATIN + FLUOROURACIL |
| 300003776 | 300002645 | 1.75 | 72.6 | Neo-adjuvant (N) | null | 2016-06-26 | Cisplatin + Docetaxel +Fluorouracil | Y | null | 300016805 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003777 | 300002645 | null | 75 | Neo-adjuvant (N) | 2016-03-14 | 2016-04-18 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016805 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003778 | 300002646 | 1.66 | 91 | null | 2014-03-20 | 2014-03-27 | Cisplatin + Docetaxel +Fluorouracil | N | null | 300016814 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003779 | 300002647 | 1.71 | 63.3 | null | 2014-04-15 | 2014-05-14 | CETUXIMAB + RT | N | Y | 300016816 | CETUXIMAB + RT |
| 300003780 | 300002647 | 1.59 | 67 | null | 2017-07-11 | 2017-08-08 | Cetuximab 7 day (Cycle 1) | N | Y | 300016816 | CETUXIMAB |
| 300003781 | 300002648 | 1.7 | 113.6 | Curative (C) | 2016-01-12 | 2016-01-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016821 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003782 | 300005998 | 1.71 | 60 | Adjuvant (A) | 2018-02-04 | 2018-02-17 | Capecitabine | N | N | 300016826 | CAPECITABINE |
| 300003783 | 300002649 | 1.7 | 73.5 | null | 2015-01-22 | 2015-01-26 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016830 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003784 | 300002650 | 1.67 | null | Neo-adjuvant (N) | 2014-04-26 | 2014-05-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300016838 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003785 | 300002651 | 1.61 | 62.7 | null | 2015-07-30 | 2015-08-04 | Cetuximab + Radiotherapy Load | 02 | N | 300016843 | CETUXIMAB + RT |
| 300003786 | 300002652 | 1.8 | 81.6 | Neo-adjuvant (N) | 2016-05-12 | 2016-06-03 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 300016844 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003787 | 300002652 | null | 77.3 | Palliative (P) | 2015-08-13 | 2015-08-19 | Carboplatin + Paclitaxel (3 weekly) | null | N | 300016844 | CARBOPLATIN + PACLITAXEL |
| 300003789 | 300002654 | 1.67 | 105.4 | Curative (C) | 2015-01-01 | 2015-01-07 | Cisplatin + Docetaxel +Fluorouracil | null | N | 300016855 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003790 | 300002655 | 1.81 | 38.35 | Palliative (P) | 2016-10-11 | 2016-10-30 | Capecitabine | 02 | N | 300016857 | CAPECITABINE |
| 300003791 | 300002655 | null | 77.7 | Neo-adjuvant (N) | 2015-11-26 | 2015-12-09 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300016857 | CISPLATIN + DOCETAXEL + FLUOROURACIL |